Lytix Biopharma AS (FRA:6BG)
Germany · Delayed Price · Currency is EUR 0.7840
+0.0100 (1.29%)
At close: Jan 30, 2026
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of €62.39 million as of January 30, 2026. Its market cap has increased by 86.31% in one year.
Market Cap
62.39M
Enterprise Value
54.71M
Revenue
32.17K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.78
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 71.47M to 62.39M, a decrease of -12.70%. That is a compound annual growth rate of -2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 62.39M | 9.22% |
| Dec 30, 2025 | 57.13M | 67.94% |
| Dec 30, 2024 | 34.01M | 95.78% |
| Dec 29, 2023 | 17.37M | -41.17% |
| Dec 30, 2022 | 29.53M | -44.70% |
| Dec 30, 2021 | 53.40M | -25.28% |
| Jun 14, 2021 | 71.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Path2 Hydrogen AG | 73.04M |
| InnoTec TSS AG | 68.90M |
| audius SE | 67.41M |
| learnd SE | 60.39M |
| WASGAU Produktions & Handels AG | 59.40M |
| capsensixx AG | 58.59M |
| Schwälbchen Molkerei Jakob Berz AG | 58.16M |
| Nordwest Handel AG | 58.01M |